Leak, Logan https://orcid.org/0000-0002-7000-9612
Wang, Ziwei https://orcid.org/0000-0002-9994-1331
Joseph, Alby J.
Johnson, Brianna https://orcid.org/0000-0003-3214-284X
Chan, Alyssa A.
Decosto, Cassandra M.
Magtanong, Leslie https://orcid.org/0000-0002-0894-3156
Ko, Pin-Joe
Lee, Weaverly Colleen https://orcid.org/0000-0002-9447-1174
Ritho, Joan
Manukian, Sophia
Millner, Alec
Chitkara, Shweta
Salinas, Jennifer J.
Skouta, Rachid
Rees, Matthew G.
Ronan, Melissa M.
Roth, Jennifer A.
Myers, Chad L. https://orcid.org/0000-0002-1026-5972
Moffat, Jason https://orcid.org/0000-0002-5663-8586
Boone, Charles https://orcid.org/0000-0002-3542-6760
Bensinger, Steven J. https://orcid.org/0000-0002-9657-4206
Nathanson, David A.
Atilla-Gokcumen, G. Ekin
Moding, Everett J. https://orcid.org/0000-0001-7913-5351
Dixon, Scott J. https://orcid.org/0000-0001-6230-8199
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01CA272485, R01HG005853, R01HG005853, R01HG005853, R01NS121319, R01CA272485)
National Science Foundation (MCB 2314338)
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-GMX463531)
Article History
Received: 7 February 2025
Accepted: 16 April 2025
First Online: 26 May 2025
Competing interests
: D.A.N. is a founder of and holds equity in Katmai Pharmaceuticals and Trethera Corporation. E.J.M. has served as a paid consultant for Guidepoint and GLG. S.J.D. is an inventor on patents related to ferroptosis. The other authors declare no competing interests.